# Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

> **NCT01884337** · PHASE4 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 557 (actual)

## Conditions studied

- Anticoagulation

## Interventions

- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT01884337
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-24
- **Primary completion:** 2018-06-04
- **Final completion:** 2018-06-04
- **Target enrollment:** 557 (ACTUAL)
- **Last updated:** 2019-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01884337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01884337, "Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01884337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*